natgillin/translations-raw huggingface dataset:
The labelling of the novel food shall bear instructions for use for the final consumers so that a maximum concentration of 5 μg/100 g of vitamin D2 in final home-baked products is not exceeded.’
Označevanje novega živila vključuje navodila za uporabo za končne potrošnike, tako da se ne preseže najvišja koncentracija 5 μg/100 g vitamina D2 v končnih, doma pečenih proizvodih.“
the entry for ‘UV-treated baker's yeast (Saccharomyces cerevisiae)’ in Table 2 (Specifications) is replaced by the following:
Vnos za „Z UV-žarki obdelan pekovski kvas (Saccharomyces cerevisiae)“ v Tabeli 2 (Specifikacije) se nadomesti z naslednjim:
Authorised Novel Food
Odobreno novo živilo
Baker's yeast (Saccharomyces cerevisiae) is treated with ultraviolet light to induce the conversion of ergosterol to vitamin D2 (ergocalciferol).
Pekovski kvas (Saccharomyces cerevisiae) se obdela z ultravijoličnimi žarki, da se sproži pretvorba ergosterola v vitamin D2 (ergokalciferol).
Vitamin D2 content in the yeast concentrate varies between 800000-3500000 IU vitamin D/100 g (200-875 μg/g).
Vsebnost vitamina D2 v koncentratu kvasa variira med 800000 in 3500000 IU vitamina D/100 g (200–875 μg/g).
The yeast may be inactivated.
Kvas je lahko inaktiviran.
The yeast concentrate is blended with regular baker's yeast in order not to exceed the maximum level in the pre-packed fresh or dry yeast for home baking.
Koncentrat kvasa je mešan z običajnim pekovskim kvasom, da se ne preseže najvišja raven v predpakiranem svežem ali suhem kvasu za domačo peko.
Tan-coloured, free-flowing granules.
Je rjavkaste barve, v obliki sipkih zrnc.
Chemical name: (5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
sopomenka: ergokalciferol
Synonym: Ergocalciferol
št.
CAS No.: 50-14-6
CAS: 50-14-6
Molecular weight: 396,65 g/mol
molekulska masa: 396,65 g/mol
Microbiological criteria for the yeast concentrate:
Mikrobiološka merila koncentrata kvasa:
Coliforms: ≤ 103/g
koliformne bakterije: ≤ 103/g
Salmonella: Absence in 25 g’
Salmonella: odsotnost v 25 g“
Commission Implementing Regulation (EU) 2018/1019
Izvedbena uredba Komisije (EU) 2018/1019
concerning the non-renewal of approval of the active substance oxasulfuron, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011
o neobnovitvi odobritve aktivne snovi oksasulfuron v skladu z Uredbo (ES) št. 1107/2009 Evropskega parlamenta in Sveta o dajanju fitofarmacevtskih sredstev v promet ter o spremembi Izvedbene uredbe Komisije (EU) št. 540/2011
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC, and in particular Article 20(1)(b) and Article 78(2) thereof,
ob upoštevanju Uredbe (ES) št. 1107/2009 Evropskega parlamenta in Sveta z dne 21. oktobra 2009 o dajanju fitofarmacevtskih sredstev v promet in razveljavitvi direktiv Sveta 79/117/EGS in 91/414/EGS ter zlasti člena 20(1)(b) in člena 78(2) Uredbe,
Commission Directive 2003/23/EC included oxasulfuron as an active substance in Annex I to Council Directive 91/414/EEC.
Oksasulfuron je bil z Direktivo Komisije 2003/23/ES vključen v Prilogo I k Direktivi Sveta 91/414/EGS kot aktivna snov.
The approval of the active substance oxasulfuron, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011, expires on 31 July 2019.
Odobritev aktivne snovi oksasulfuron, kot je določena v delu A Priloge k Izvedbeni uredbi (EU) št. 540/2011, preneha veljati 31. julija 2019.
An application for the renewal of the approval of oxasulfuron was submitted in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 within the time period provided for in that Article.
Zahtevek za obnovitev odobritve oksasulfurona je bil predložen v skladu s členom 1 Izvedbene uredbe Komisije (EU) št. 844/2012 v roku, določenem v navedenem členu.
The rapporteur Member State prepared a renewal assessment report in consultation with the co-rapporteur Member State and submitted it to the European Food Safety Authority (‘the Authority’) and the Commission on 29 January 2016.
Država članica poročevalka je pripravila poročilo o oceni obnovitve v posvetovanju z državo članico soporočevalko ter ga 29. januarja 2016 predložila Evropski agenciji za varnost hrane (v nadaljnjem besedilu: Agencija) in Komisiji.
On 2 February 2017 the Authority communicated to the Commission its conclusion on whether oxasulfuron can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
Agencija je 2. februarja 2017 Komisiji predložila svoj sklep o tem, ali se za oksasulfuron lahko pričakuje, da bo izpolnjeval merila za odobritev iz člena 4 Uredbe (ES) št. 1107/2009.
The Authority identified a large number of data gaps resulting in the inability to finalise the risk assessment in several areas.
Agencija je ugotovila številne pomanjkljivosti pri podatkih, zaradi katerih ni bilo mogoče dokončati ocene tveganja na več področjih.
In particular, the available information on oxasulfuron and its metabolites did not allow finalising the assessment of the overall consumer exposure, the groundwater exposure, the risk to aquatic organisms, earthworms, soil macro- and microorganisms and non-target terrestrial plants.
Zlasti razpoložljive informacije o oksasulfuronu in njegovih metabolitih niso omogočale dokončanja ocene splošne izpostavljenosti potrošnikov, izpostavljenosti podzemne vode, tveganja za vodne organizme, deževnike, talne makro- in mikroorganizme in neciljne kopenske rastline.
The Commission presented the draft renewal report and a draft Regulation for oxasulfuron to the Standing Committee on Plants, Animals, Food and Feed on 19 July 2017.
Komisija je osnutek poročila o obnovitvi in osnutek uredbe o oksasulfuronu 19. julija 2017 predložila Stalnemu odboru za rastline, živali, hrano in krmo.
Furthermore, in accordance with the third subparagraph of Article 14(1) of Implementing Regulation (EU) No 844/2012, the Commission invited the applicant to submit comments on the draft renewal report.
Pozvala ga je tudi, da v skladu s tretjim pododstavkom člena 14(1) Izvedbene uredbe (EU) št. 844/2012 predloži pripombe k osnutku poročila o obnovitvi odobritve.
However, despite the arguments put forward by the applicant, the concerns referred to in recital 9 could not be eliminated.
Kljub argumentom, ki jih je predložil vlagatelj, pomislekov iz uvodne izjave 9 ni bilo mogoče odpraviti.
Consequently, it has not been established with respect to one or more representative uses of at least one plant protection product that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied.
Posledično je bilo za eno ali več reprezentativnih uporab vsaj enega fitofarmacevtskega sredstva ugotovljeno, da merila za odobritev iz člena 4 Uredbe (ES) št. 1107/2009 niso izpolnjena.
The approval of the active substance oxasulfuron should therefore not be renewed.
Odobritev aktivne snovi oksasulfuron se zato ne bi smela obnoviti.
Member States should be allowed sufficient time to withdraw authorisations for plant protection products containing oxasulfuron.
Državam članicam bi bilo treba omogočiti dovolj časa za preklic registracij fitofarmacevtskih sredstev, ki vsebujejo oksasulfuron.
For plant protection products containing oxasulfuron, where Member States grant any grace period in accordance with Article 46 of Regulation (EC) No 1107/2009, that period should, at the latest, expire on 8 November 2019.
Za fitofarmacevtska sredstva, ki vsebujejo oksasulfuron in pri katerih države članice odobrijo morebitno prehodno obdobje v skladu s členom 46 Uredbe (ES) št. 1107/2009, bi se moralo navedeno obdobje izteči najpozneje 8. novembra 2019.
Commission Implementing Regulation (EU) 2018/917 extended the expiry date of oxasulfuron to 31 July 2019 in order to allow the renewal process to be completed before the expiry of the approval of that substance.
Z Izvedbeno uredbo Komisije (EU) 2018/917 je bil datum veljavnosti odobritve oksasulfurona podaljšan do 31. julija 2019, da bi se omogočil zaključek postopka obnovitve pred prenehanjem veljavnosti odobritve navedene snovi.
Given that a decision is taken ahead of that extended expiry date, this Regulation should apply as soon as possible.
Ker pa se sklep sprejme pred navedenim podaljšanim datumom veljavnosti odobritve, bi se ta uredba morala začeti uporabljati čim prej.
This Regulation does not prejudice the submission of a further application for the approval of oxasulfuron in accordance with Article 7 of Regulation (EC) No 1107/2009.
Ta uredba ne vpliva na predložitev ponovnega zahtevka za odobritev oksasulfurona v skladu s členom 7 Uredbe (ES) št. 1107/2009.
The approval of the active substance oxasulfuron is not renewed.
Odobritev aktivne snovi oksasulfuron se ne obnovi.
In Part A of the Annex to Implementing Regulation (EU) No 540/2011, row 42 on oxasulfuron, is deleted.
V delu A Priloge k Izvedbeni uredbi (EU) št. 540/2011 se vrstica 42 za oksasulfuron črta.
Member States shall withdraw authorisations for plant protection products containing oxasulfuron as active substance by 8 November 2018 at the latest.
Države članice prekličejo registracije fitofarmacevtskih sredstev, ki vsebujejo oksasulfuron kot aktivno snov, najpozneje do 8. novembra 2018.
Any grace period granted by Member States in accordance with Article 20 of Regulation (EC) No 1107/2009 shall be as short as possible and shall expire by 8 November 2019 at the latest.
Morebitno prehodno obdobje, ki ga države članice odobrijo v skladu s členom 20 Uredbe (ES) št. 1107/2009, je čim krajše, izteče pa se najpozneje 8. novembra 2019.
Commission Directive 2003/23/EC of 25 March 2003 amending Council Directive 91/414/EEC to include imazamox, oxasulfuron, ethoxysulfuron, foramsulfuron, oxadiargyl and cyazofamid as active substances (OJ L 81, 28.3.2003, p. 39).
Direktiva Komisije 2003/23/ES z dne 25. marca 2003 o spremembi Direktive Sveta 91/414/EGS za vključitev imazamoks, oksasulfuron, etoksisulfuron, foramsulfuron, oksadiargil in ciazofamid na seznam aktivnih snovi (UL L 81, 28.3.2003, str. 39).
EFSA Journal 2017;15(2):4722, 33 pp. doi:10.2903/j.efsa.2017.4722.
EFSA Journal 2017;15(2):4722, 33 str. doi:10.2903/j.efsa.2017.4722.
Commission Implementing Regulation (EU) 2018/917 of 27 June 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, carvone, chlorpropham, cyazofamid, desmedipham, dimethoate, dimethomorph, diquat, ethephon, ethoprophos, etoxazole, famoxadone, fenamidone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, Gliocladium catenulatum strain: J1446, isoxaflutole, metalaxyl-m, methiocarb, methoxyfenozide, metribuzin, milbemectin, oxasulfuron, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, pymetrozine and s-metolachlor (OJ L 163, 28.6.2018, p. 13).
Izvedbena uredba Komisije (EU) 2018/917 z dne 27. junija 2018 o spremembi Izvedbene Uredbe (EU) št. 540/2011 glede podaljšanja obdobij odobritve za aktivne snovi alfa-cipermetrin, beflubutamid, benalaksil, bentiavalikarb, bifenazat, boskalid, bromoksinil, kaptan, karvon, klorprofam, ciazofamid, desmedifam, dimetoat, dimetomorf, dikvat, etefon, etoprofos, etoksazol, famoksadon, fenamidon, fenamifos, flumioksazin, fluoksastrobin, folpet, foramsulfuron, formetanat, Gliocladium catenulatum sev: J1446, izoksaflutol, metalaksil-m, metiokarb, metoksifenozid, metribuzin, milbemektin, oksasulfuron, Paecilomyces lilacinus sev 251, fenmedifam, fosmet, pirimifos-metil, propamokarb, protiokonazol, pimetrozin in S-metolaklor (UL L 163, 28.6.2018, str. 13).
Commission Implementing Regulation (EU) 2018/1023
Izvedbena uredba Komisije (EU) 2018/1023
of 23 July 2018
z dne 23. julija 2018
correcting Implementing Regulation (EU) 2017/2470 establishing the Union list of novel foods
o popravku Izvedbene uredbe (EU) 2017/2470 o oblikovanju seznama Unije novih živil
Having regard to Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods, amending Regulation (EU) No 1169/2011 of the European Parliament and of the Council and repealing Regulation (EC) No 258/97 of the European Parliament and of the Council and Commission Regulation (EC) No 1852/2001, and in particular Article 8 thereof,
ob upoštevanju Uredbe (EU) 2015/2283 Evropskega parlamenta in Sveta o novih živilih, spremembi Uredbe (EU) št. 1169/2011 Evropskega parlamenta in Sveta in razveljavitvi Uredbe (ES) št. 258/97 Evropskega parlamenta in Sveta ter Uredbe Komisije (ES) št. 1852/2001 in zlasti člena 8 Uredbe,
Pursuant to Article 8 of Regulation (EU) 2015/2283, the Commission is to establish, by 1 January 2018, the Union list of novel foods authorised or notified under Regulation (EC) No 258/97 of the European Parliament and of the Council.
V skladu s členom 8 Uredbe (EU) 2015/2283 mora Komisija do 1. januarja 2018 oblikovati seznam Unije novih živil, odobrenih ali priglašenih na podlagi Uredbe (ES) št. 258/97 Evropskega parlamenta in Sveta.
The Union list of novel foods authorised or notified under Regulation (EC) No 258/97 was established by Commission Implementing Regulation (EU) 2017/2470.
Seznam Unije novih živil, odobrenih ali priglašenih na podlagi Uredbe (ES) št. 258/97, je bil oblikovan z Izvedbeno uredbo Komisije (EU) 2017/2470.
A number of products were authorised or notified under Regulation (EC) No 258/97 during the period between the Standing Committee vote on the Union list on 6 December 2017 and the date of application of Regulation (EU) 2015/2283 on 1 January 2018.
Družba Demethra Biotech S.r.l. je 19. decembra 2017 v skladu s členom 5 Uredbe (ES) št. 258/97 uradno obvestila Komisijo, da je na trg Unije dala novo živilo „izvleček Echinacea purpurea iz celičnih kultur“.
These products should therefore be included in the Union list established through Implementing Regulation (EU) 2017/2470.
To novo živilo ni bilo vključeno na seznam Unije.
On 19 December 2017, the company Demethra Biotech S.r.l. notified the Commission that it placed the novel food ‘Echinacea purpurea extract from cell cultures’ on the Union market pursuant to Article 5 of Regulation (EC) No 258/97.
Zato bi bilo treba v tabeli 1 in 2 Priloge k Izvedbeni uredbi (EU) 2017/2470 dodati nov vnos.
This novel food was not included in the Union list.
Družbi DuPont Nutrition & Biosciences ApS in FrieslandCampina Nederland BV sta 21. in 22. decembra 2017 v skladu s členom 5 Uredbe (ES) št. 258/97 uradno obvestili Komisijo, da sta na trg Unije dali novo živilo „2’-fukozillaktoza (mikrobni vir)“.
Therefore, a new entry should be added to Tables 1 and 2 of the Annex to Implementing Regulation (EU) 2017/2470.
„2’-fukozillaktoza (mikrobni vir)“ je že bila vključena v Prilogo k Izvedbeni uredbi (EU) 2017/2470.
On 21 and 22 December 2017, two companies, DuPont Nutrition & Biosciences ApS and FrieslandCampina Nederland BV, notified the Commission that they placed the novel food ‘2'-Fucosyllactose (microbial source)’ on the Union market pursuant to Article 5 of Regulation (EC) No 258/97.
Navedeni novi obvestili se nanašata na spremembo številčnih vrednosti več parametrov, navedenih v specifikacijah tega novega živila, zato bi bilo treba vnos „2’-fukozillaktoza (mikrobni vir)“ v tabeli 2 Priloge k Izvedbeni uredbi (EU) 2017/2470 ustrezno popraviti.
‘2'-Fucosyllactose (microbial source)’ was already included in the Annex to Implementing Regulation (EU) 2017/2470.
Družba c-LEcta GmbH je 20. decembra 2017 v skladu s členom 5 Uredbe (ES) št. 258/97 uradno obvestila Komisijo, da je na trg Unije dala novo živilo „trehaloza“.
Those new notifications modify the numerical values of several parameters listed in the specifications of this novel food and therefore, the entry ‘2'-Fucosyllactose (microbial source)’ in Table 2 of the Annex to Implementing Regulation (EU) 2017/2470 should be corrected accordingly.
„Trehaloza“ je bila vključena v Prilogo k Izvedbeni uredbi (EU) 2017/2470.
On 20 December 2017, the company c-LEcta GmbH notified the Commission that it placed the novel food ‘Trehalose’ on the Union market pursuant to Article 5 of Regulation (EC) No 258/97.
Navedena nova priglasitev se nanaša na nov vir trehaloze, in sicer saharozo.
‘Trehalose’ was included in the Annex to Implementing Regulation (EU) 2017/2470.
Zato bi bilo treba specifikacije v vnosu za „trehalozo“ v tabeli 2 Priloge k Izvedbeni uredbi (EU) 2017/2470 ustrezno popraviti.
That new notification concerns a new source of trehalose, sucrose.
Po objavi Izvedbene uredbe (EU) 2017/2470 so bile ugotovljene številne napake ali izpustitve v zvezi s specifikacijami ali pogoji za uporabo več odobrenih novih živil.
Therefore, the specifications of the entry ‘Trehalose’ in Table 2 of the Annex to Implementing Regulation (EU) 2017/2470 should be corrected accordingly.
Zato bi bilo treba seznam Unije iz Priloge k Izvedbeni uredbi (EU) 2017/2470 popraviti.
After the publication of Implementing Regulation (EU) 2017/2470, a number of errors or omissions were noted concerning the specifications or the conditions of use of a number of authorised novel foods.
Novo živilo „L-alanil-L-glutamin“ je bilo v skladu s členom 5 Uredbe (ES) št. 258/97 odobreno pod določenimi pogoji za uporabo.
Therefore, the Union list established in the Annex to Implementing Regulation (EU) 2017/2470 should be corrected.
Kategorija „pijače, namenjene osebam z veliko energijsko porabo, predvsem športnikom“ je bila napačno izpuščena.
The novel food ‘L-Alanyl-L-Glutamine’ was authorised under certain conditions of use pursuant to Article 5 of Regulation (EC) No 258/97.
Zato je potreben popravek, s katerim bo v vnos za „L-alanil-L-glutamin“ v tabeli 1 Priloge k Izvedbeni uredbi (EU) 2017/2470 dodana kategorija „pijače, namenjene osebam z veliko energijsko porabo, predvsem športnikom“ kot dovoljena kategorija živil.
The category ‘Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen’ was erroneously omitted.
Novo živilo „glukozamin HCl“ je bilo v skladu s členom 5 Uredbe (ES) št. 258/97 odobreno pod določenimi pogoji za uporabo.
Therefore, a correction adding ‘Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen’ as allowed food category in the entry ‘L-Alanyl-L-Glutamine’ in Table 1 of the Annex to Implementing Regulation (EU) 2017/2470 is necessary.
Kategorija živil „pijače na osnovi mleka in podobni izdelki, namenjeni majhnim otrokom“ je bila napačno dodana in bi jo bilo treba iz tega vnosa črtati.
The novel food ‘Glucosamine HCl’ was authorised under certain conditions of use pursuant to Article 5 of Regulation (EC) No 258/97.
Zato je potreben popravek vnosa za „glukozamin HCl“ v tabeli 1 Priloge k Izvedbeni uredbi (EU) 2017/2470.
The food category ‘Milk-based drinks and similar products intended for young children’ was added erroneously and should be deleted from this entry.
Novo živilo „lakto-N-neotetraoza“ je bilo z Izvedbenim sklepom Komisije (EU) 2016/375 odobreno pod določenimi pogoji za uporabo in ob upoštevanju največjih dovoljenih vrednosti.
A correction in the entry ‘Glucosamine HCl’ in Table 1 of the Annex to Implementing Regulation (EU) 2017/2470 is therefore necessary.
Besedilo „v koncentraciji do 1,2 g/l“ je bilo napačno dodano in bi ga bilo treba črtati iz kategorije živil „pijače na osnovi mleka in podobni izdelki, namenjeni majhnim otrokom“ za to novo živilo.
The novel food ‘Lacto-N-neotetraose’ was authorised under certain conditions of use and maximum levels by Commission Implementing Decision (EU) 2016/375.
Zato je potreben popravek vnosa za „lakto-N-neotetraozo“ v tabeli 1 Priloge k Izvedbeni uredbi (EU) 2017/2470.
The wording ‘at concentrations up to 1,2 g/l’ was added erroneously and should be removed from the food category ‘Milk-based drinks and similar products intended for young children’ for this novel food.
Novo živilo „izvleček iz pšeničnih kalčkov (Triticum aestevium), bogat s spermidinom“ je bilo v skladu s členom 5 Uredbe (ES) št. 258/97 odobreno pod določenimi pogoji za uporabo za „odraslo populacijo, razen nosečnic in doječih mater“.
Therefore, a correction of the entry ‘Lacto-N-neotetraose’ in Table 1 of the Annex to Implementing Regulation (EU) 2017/2470 is necessary.
Vendar izključitev nosečnic in doječih mater napačno ni bila vključena na seznam Unije.
The novel food ‘Spermidine-rich wheat germ extract (Triticum aestivum)’ was authorised under certain conditions of use for ‘adult population excluding pregnant and lactating women’ pursuant to Article 5 of Regulation (EC) No 258/97.
Zato je potreben popravek vnosa za „izvleček iz pšeničnih kalčkov (Triticum aestevium), bogat s spermidinom“ v tabeli 1 Priloge k Izvedbeni uredbi (EU) 2017/2470.
However, the exclusion of pregnant and lactating women erroneously did not feature in the Union list.
Novo živilo „olje iz krila vrste Euphausia superba, bogato s fosfolipidi“ so pod določenimi pogoji za uporabo odobrili finski pristojni organi.
Therefore, a correction of this entry in Table 2 of the Annex to Implementing Regulation (EU) 2017/2470 is necessary.
Novo živilo „seme oljne kadulje (Salvia hispanica)“ je bilo z Odločbo Komisije 2009/827/ES prvotno odobreno pod določenimi pogoji za uporabo.
The specifications erroneously added the following requirement: ‘Oxidative stability: all food products containing Antarctic Krill oil rich in phospholipids from Euphausia superba should demonstrate oxidative stability by appropriate and recognised national/international test methodology (e.g. AOAC)’.
Zato je potreben popravek vnosa za „seme oljne kadulje (Salvia hispanica)“ v tabeli 2 Priloge k Izvedbeni uredbi (EU) 2017/2470.
This requirement should be removed.
Novo živilo „izvleček hitosana iz gliv (Agaricus bisporus; Aspergillus niger)“ je bilo v skladu s členom 5 Uredbe (ES) št. 258/97 prvotno odobreno pod določenimi pogoji za uporabo.
Therefore, a correction of the entry ‘Antarctic Krill oil rich in phospholipids from Euphausia superba’ in Table 2 of the Annex to Implementing Regulation (EU) 2017/2470 is necessary.
V njegovih specifikacijah je bila napačno dodana naslednja zahteva: „sposobnost vezave maščob 800 × 9 w/mokro maso): pozitivna“.
The novel food ‘Chia seeds (Salvia hispanica)’ was initially authorised under certain conditions of use by Commission Decision 2009/827/EC.
To zahtevo bi bilo treba nadomestiti z zahtevo „sposobnost vezave maščob 800 × (m/m mokre mase): pozitivna“.
The specifications erroneously added the following requirement: ‘(EU: carbohydrates are available = sugar + starch)’.
Zato je potreben popravek vnosa za „izvleček hitosana iz gliv (Agaricus bisporus; Aspergillus niger)“ v tabeli 2 Priloge k Izvedbeni uredbi (EU) 2017/2470.
Therefore, a correction of the entry ‘Chia seeds (Salvia hispanica)’ in Table 2 of the Annex to Implementing Regulation (EU) 2017/2470 is necessary.
Novo živilo „citikolin“ je bilo z Izvedbenim sklepom Komisije 2014/423/EU odobreno pod določenimi pogoji za uporabo.
The novel food ‘Chitosan extract from fungi (Agaricus bisporus; Aspergillus niger)’ was initially authorised under certain conditions of use pursuant to Article 5 of Regulation (EC) No 258/97.
V tabeli 2 Priloge k Izvedbeni uredbi (EU) 2017/2470 se specifikacije novega živila „citikolin“ nanašajo na citikolin, proizveden bodisi s sintetičnim ali mikrobiološkim procesom.
The specifications erroneously added the following requirement: ‘Fat binding capacity 800 x 9 w/wet weight): pass’.
Po objavi navedene uredbe je postalo jasno, da mikrobiološki proces za proizvajanje citikolina vključuje tudi sintetični postopek.
This requirement should be replaced by ‘Fat binding capacity 800 x (w/w wet weight): pass’.
Zato bi bilo treba specifikacije v zvezi s „citikolinom“ v tabeli 2 Priloge k Izvedbeni uredbi (EU) 2017/2470 popraviti, da bodo vključevale le mikrobiološki proces proizvajanja.